Vaccine News and Research

Latest Vaccine News and Research

Cell atlas helps better understand the biology of tropical disease parasite

The first cell atlas of an important life stage of Schistosoma mansoni, a parasitic worm that poses a risk to hundreds of millions of people each year, has been developed by researchers at the Wellcome Sanger Institute and their collaborators.

18 Dec 2020

AAHMS report spells out the necessary steps to maintain control over COVID-19 in 2021

High levels of testing, efficient vaccine distribution and addressing pandemic mental health impacts are critical if Australia is to maintain control over COVID-19 in 2021, the country’s learned body for health and medical sciences has concluded.

18 Dec 2020

Study: At least a fifth of the world’s population may not have access to covid-19 vaccine until 2022

Nearly a quarter of the world’s population may not have access to a covid-19 vaccine until at least 2022, warns a study published by The BMJ today.

18 Dec 2020

Experts to share the lessons learnt from COVID-19 first wave

The Physiological Society and the Intensive Care Society have come together to host an exciting three-day virtual conference this week, which will review the challenges of understanding the pathophysiological changes occurring throughout the body following COVID-19 infection.

18 Dec 2020

Abbott gets CE Mark for new quantitative SARS-CoV-2 IgG lab-based serology test

Abbott announced today it received CE Mark for its new quantitative SARS-CoV-2 IgG (Immunoglobulin G) lab-based serology test.

18 Dec 2020

Vi-DT typhoid conjugate vaccine met primary endpoints in phase III study

Vi-DT typhoid conjugate vaccine, developed jointly by the International Vaccine Institute (IVI) and SK bioscience, has met the primary endpoints in a phase III study in Nepal.

17 Dec 2020

PVP at Boston Children's awarded $1 million to extend research into adjuvant-based vaccines

For a vaccine to be most effective, sometimes nature needs a little 'extra' something. That something is often an adjuvant -- small molecules added to a vaccine that boost the body's immune response.

17 Dec 2020

KHN’s ‘What the Health?’: All I want for Christmas is a COVID relief bill

Congress appears to be inching ever closer to agreement on a long-delayed COVID-19 relief bill, which would extend unemployment insurance and other emergency programs set to expire in the next several days.

17 Dec 2020

Hepatitis C virus drugs synergize with remdesivir against SARS-CoV-2 in vitro

SARS-CoV-2 has infected over 71.5 million people and claimed over 1.6 million lives globally since December 2019.

17 Dec 2020

Researchers evaluate changes in measles vaccination rates before COVID-19 pandemic

One consequence of the COVID-19 pandemic is that more families are putting off their children's preventive care visits, causing pediatric providers to worry about missed vaccines.

17 Dec 2020

Scientists develop new vaccine to counter the effects of synthetic cannabinoids

Made in clandestine laboratories and sold widely across the United States, the diverse class of drugs known as synthetic cannabinoids presents a growing public health threat.

17 Dec 2020

Researchers use GIS software to map COVID-19 vaccine administration facilities

As the biggest vaccination effort in U.S. history gets underway, several states may not have a sufficient number of facilities in some areas to administer the COVID-19 vaccine to all residents who want it, according to a new analysis from the University of Pittsburgh School of Pharmacy and the nonprofit West Health Policy Center.

17 Dec 2020

LRA survey: Two-thirds of people with lupus are willing to take COVID-19 vaccine

Two out of three people with lupus (64%) are willing to take a COVID-19 vaccine if it is free and determined safe by scientists according to results of a survey conducted by the Lupus Research Alliance.

16 Dec 2020

Survey suggests COVID-19 vaccine hesitancy stems from a distrust in the vaccine development and approval process

Survey results of COVID-19 vaccine hesitancy suggest that people are less likely to get the COVID-19 vaccine than the number of people who got the flu shot.

16 Dec 2020

BAT advances COVID-19 vaccine candidate into phase-I clinical trial

The COVID-19 vaccine candidate (KBP-COVID-19; NCT04473690) will become one of a number of potential vaccines to have progressed beyond pre-clinical testing.

16 Dec 2020

AI-based study of social media maps SARS-CoV-2 vaccine hesitancy across the US

Researchers from the University of Rochester, USA, has produced an AI-based study that analyzes the social media platform Twitter to gauge public opinions in the US surrounding SARS-CoV-2 vaccines to shed greater light on this issue.

15 Dec 2020

Could wastewater surveillance help track SARS-COV-2 community outbreaks?

A team of US-based researchers recently conducted an illuminating study that explores this method and its potential uses. In doing so, they have underscored the potential utility of wastewater surveillance in managing SARS-CoV-2 outbreaks.

15 Dec 2020

Trump’s wrong. 15% ‘herd immunity’ is not on par with strength of a vaccine

During a Dec. 8 press conference about Operation Warp Speed, President Donald Trump likened the spread of the coronavirus throughout the population — which experts agree bestows some immunity on the people who became ill — to having a COVID-19 vaccine.

15 Dec 2020

Drug may increase vaccine protection in older adults

A drug that boosts the removal of cellular debris in immune cells may increase the protective effects of vaccines in older adults, a study published today in eLife shows.

15 Dec 2020

Pediatricians want kids to be part of COVID vaccine trials

If clinical trials for COVID-19 vaccines aren't expanded soon to include children, it's unlikely that even kids in their teens will be vaccinated in time for the next school year.

15 Dec 2020